Sanofi traded at 77.84 this Thursday September 29th, decreasing 0.87 or 1.11 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 5.76 percent. Over the last 12 months, its price fell by 6.31 percent. Looking ahead, we forecast Sanofi to be priced at 75.91 by the end of this quarter and at 67.83 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
77.84
Daily Change
-1.11%
Yearly
-6.31%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 142.69 -1.91 -1.32% 32.28%
Aena 106.95 -2.10 -1.93% -28.37%
Alcon AG 55.44 -0.80 -1.42% -27.09%
Almirall SA 9.73 0.32 3.35% -29.08%
Amgen 228.50 -2.48 -1.07% 7.45%
Amarin 1.10 -0.09 -7.56% -78.43%
Artemis Alpha 262.00 -13.00 -4.73% -38.93%
AstraZeneca 9,933.00 -143.00 -1.42% 10.88%
Bayer 47.72 -0.47 -0.98% 1.52%
Biogen 264.20 -12.41 -4.49% -6.64%
BMW 69.13 -2.45 -3.42% -16.47%
Bristol-Myers Squibb 71.78 -0.28 -0.39% 21.31%
Daimler 52.43 -2.01 -3.69% -31.66%
Vinci 82.61 -1.62 -1.92% -8.36%
Essilor 141.00 -1.70 -1.19% -14.80%
Fresenius Medical Care 28.41 -0.50 -1.73% -53.32%
Fresenius 21.22 -0.44 -2.03% -48.91%
Genmab 2,428.00 -63.00 -2.53% -13.56%
Gilead Sciences 63.03 -0.90 -1.41% -9.76%
Galapagos 42.82 -1.17 -2.66% -5.18%
GRIFOLS 8.83 -0.25 -2.73% -58.09%
GlaxoSmithKline 1,315.80 -25.80 -1.92% -6.26%
Hikma Pharmaceutical 1,349.50 -41.00 -2.95% -44.92%
J&J 164.60 -1.76 -1.06% 1.92%
Eli Lilly 329.84 -4.54 -1.36% 42.76%
Lonza Group 468.30 -4.10 -0.87% -33.25%
Merck 163.60 1.05 0.65% -12.82%
Merck & Co 86.70 -0.08 -0.09% 15.43%
Novartis 74.92 0.10 0.13% -2.49%
Orion 42.16 -0.24 -0.57% 23.09%
Pfizer 44.24 -0.22 -0.50% 2.86%
Philips 15.64 -0.10 -0.66% -59.20%
Recordati 36.74 -0.83 -2.21% -26.93%
Regeneron Pharmaceuticals 692.17 -13.25 -1.88% 14.37%
Roche Holding 320.25 -5.20 -1.60% -6.35%
Sanofi 77.84 -0.87 -1.11% -6.31%
SAP 81.87 -1.28 -1.54% -29.95%
UCB 71.12 0.98 1.40% -26.53%
Volkswagen 128.46 -9.44 -6.85% -33.66%

Indexes Price Day Year
EU50 3287 -56.26 -1.69% -18.80%
FR40 5689 -88.14 -1.53% -12.75%
EU100 1101 -18.07 -1.61% -13.69%

Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.